Indacaterol maleate

Size	Price	Stock	Quantity
Get Quotation Now Add to Cart Bulk Inquiry

Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.

Chemical Information

Product name：Indacaterol maleate	Purity：98% min
CAS NO：753498-25-8	Solubility：DMSO : 100 mg/mL (196.63 mM)
Molecular Formula：C₂₈H₃₂N₂O₇	Package：Package according to customer requirements
Molecular Weight：508.563	Storage：Store at -20℃

Quality control

COA

Remarks

Indacaterol is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis. It was approved in 2009. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler.

Indacaterol (QAB149) maleate is an ultra-long-acting β-adrenoceptor agonist.

Adrenergic Receptor Inhibitors Related Products:

Indacaterol; Nebivolol hydrochloride; Nebivolol; Betaxolol; Betaxolol HCl; Doxazosin Mesylate; Alfuzosin HCl; Silodosin; Prazosin Hydrochloride; Terazosin hydrochloride dihydrate; Sotalol hydrochloride; Cisatracurium besylate; Ivabradine hydrochloride; Vilanterol Trifenate

References

[1]. Battram, C., et al., In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-o ne (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther, 2006. 317(2): p. 762-70.

[2]. Sturton, R.G., et al., Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices. J Pharmacol Exp Ther, 2008. 324(1): p. 270-5.